Global Radiopharmaceuticals in Nuclear Medicine Market 2020-2026,With Breakdown Data of Capacity, Sales, Revenue, Price, Cost and Gross Profit

Global Radiopharmaceuticals in Nuclear Medicine Market 2020-2026,With Breakdown Data of Capacity, Sales, Revenue, Price, Cost and Gross Profit

Table of Contents

Global Radiopharmaceuticals in Nuclear Medicine Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Diagnostic Radiopharmaceuticals
1.3.2 Therapy Radiopharmaceuticals
1.3.3 Enriched Stable Isotopes
1.4 Application Overview
1.4.1 Diagnostic Application
1.4.2 Therapeutic Application
1.4.3 Research
1.4.4 Pharmaceutical
1.4.5 Other
1.5 Industrial Chain
1.5.1 Radiopharmaceuticals in Nuclear Medicine Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Diagnostic Radiopharmaceuticals
2.1.2 Therapy Radiopharmaceuticals
2.1.3 Enriched Stable Isotopes
2.2 The Overall Market Performance(Value)
2.2.1 Diagnostic Radiopharmaceuticals
2.2.2 Therapy Radiopharmaceuticals
2.2.3 Enriched Stable Isotopes
3 Global Radiopharmaceuticals in Nuclear Medicine Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Diagnostic Application
3.3 Therapeutic Application
3.4 Research
3.5 Pharmaceutical
3.6 Other
4 Competitive Analysis
4.1 Bracco Imaging S.P.A.
4.1.1 Bracco Imaging S.P.A. Profiles
4.1.2 Bracco Imaging S.P.A. Product Information
4.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Business Performance
4.1.4 SWOT Analysis
4.2 Cambridge Isotope Laboratories, Inc.
4.2.1 Cambridge Isotope Laboratories, Inc. Profiles
4.2.2 Cambridge Isotope Laboratories, Inc. Product Information
4.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
4.2.4 SWOT Analysis
4.3 Cardinal Health, Inc.
4.3.1 Cardinal Health, Inc. Profiles
4.3.2 Cardinal Health, Inc. Product Information
4.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
4.3.4 SWOT Analysis
4.4 Covidien, Plc
4.4.1 Covidien, Plc Profiles
4.4.2 Covidien, Plc Product Information
4.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Business Performance
4.4.4 SWOT Analysis
4.5 Eczacibasi-Monrol
4.5.1 Eczacibasi-Monrol Profiles
4.5.2 Eczacibasi-Monrol Product Information
4.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Business Performance
4.5.4 SWOT Analysis
4.6 Fujifilm Holdings Corporation
4.6.1 Fujifilm Holdings Corporation Profiles
4.6.2 Fujifilm Holdings Corporation Product Information
4.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Business Performance
4.6.4 SWOT Analysis
4.7 GE Healthcare (Subsidiary Of General Electric Company)
4.7.1 GE Healthcare (Subsidiary Of General Electric Company) Profiles
4.7.2 GE Healthcare (Subsidiary Of General Electric Company) Product Information
4.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Business Performance
4.7.4 SWOT Analysis
4.8 IBA Group
4.8.1 IBA Group Profiles
4.8.2 IBA Group Product Information
4.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Business Performance
4.8.4 SWOT Analysis
4.9 Isotec, Inc. (Sigma-Aldrich)
4.9.1 Isotec, Inc. (Sigma-Aldrich) Profiles
4.9.2 Isotec, Inc. (Sigma-Aldrich) Product Information
4.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Business Performance
4.9.4 SWOT Analysis
4.10 Lantheus Medical Imaging, Inc.
4.10.1 Lantheus Medical Imaging, Inc. Profiles
4.10.2 Lantheus Medical Imaging, Inc. Product Information
4.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Business Performance
4.10.4 SWOT Analysis
4.11 Nordion, Inc.
4.12 Ntp Radioisotopes (Pty), Ltd.
4.13 Siemens Healthcare (Subsidiary Of Siemens AG)
4.14 Taiyo Nippon Sanso Corporation
4.15 Urenco Limited
4.16 Rotem Industries, Ltd., Inc.
4.17 Australian Nuclear Association And Technology Organization (ANSTO)
4.18 Board of Radiation And Isotope Technology (BRIT)
4.19 Institute of Atomic Energy Polatom Radioisotope Centre
4.20 Institute of Isotopes Co., Ltd.
4.21 Institute Of Radioelement (IRE)
5 Competitive Lanscape
5.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global Radiopharmaceuticals in Nuclear Medicine Market Assessment by Regions
7.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) by Regions (2014-2020)
7.5 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
8.2 China Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
8.3 USA Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
8.4 Europe Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
8.5 Japan Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
8.6 Korea Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
8.7 India Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
8.9 South America Radiopharmaceuticals in Nuclear Medicine Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global Radiopharmaceuticals in Nuclear Medicine Major Manufacturers
11 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Regions
11.1 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
11.1.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity Forecast by Regions (2021-2026)
11.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Regions (2021-2026)
11.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Forecast by Regions (2021-2026)
11.2 China Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
11.3 USA Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
11.4 Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
11.5 Japan Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
11.6 Korea Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
11.7 India Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
11.8 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
11.9 South America Radiopharmaceuticals in Nuclear Medicine Market Forecast (2021-2026)
12 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 Diagnostic Radiopharmaceuticals
12.3 Therapy Radiopharmaceuticals
12.4 Enriched Stable Isotopes
13 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 Diagnostic Application
13.3 Therapeutic Application
13.4 Research
13.5 Pharmaceutical
13.6 Other
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global Radiopharmaceuticals in Nuclear Medicine Average Price Forecast (2021-2026)
14.2 Global Radiopharmaceuticals in Nuclear Medicine Gross Profit Forecast (2021-2026)
15 Conclusion

List of Tables and Figures

Figure Product Picture of Radiopharmaceuticals in Nuclear Medicine
Table Manufacturers List in the Report
Table Manufacturers Capacity Market Share (%) (2018-2019)
Table Manufacturers Sales Market Share (%) (2018-2019)
Table Sales Market Share (%) by Regions in (2018-2019)
Table Sales Market Share (%) by Type in (2018-2019)
Figure Diagnostic Radiopharmaceuticals Product Picture
Table Major Manufacturers of Diagnostic Radiopharmaceuticals
Figure Therapy Radiopharmaceuticals Product Picture
Table Major Manufacturers of Therapy Radiopharmaceuticals
Figure Enriched Stable Isotopes Product Picture
Table Major Manufacturers of Enriched Stable Isotopes
Table Sales Market Share (%) by Application in (2018-2019)
Figure Diagnostic Application Examples
Key Downstream Customer in Diagnostic Application
Figure Therapeutic Application Examples
Key Downstream Customer in Therapeutic Application
Figure Research Examples
Key Downstream Customer in Research
Figure Pharmaceutical Examples
Key Downstream Customer in Pharmaceutical
Figure Other Examples
Key Downstream Customer in Other
Figure Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine
Table Key Suppliers of Raw Material/Components
Figure Representative Downstream Enterprises of Radiopharmaceuticals in Nuclear Medicine
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Type (2014-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison by Type in 2014 and 2020
Table Sales (K Units) and Growth Rate (2014-2020)
Figure Sales (K Units) and Growth Rate (2014-2020)
Table Sales (K Units) and Growth Rate (2014-2020)
Figure Sales (K Units) and Growth Rate (2014-2020)
Table Sales (K Units) and Growth Rate (2014-2020)
Figure Sales (K Units) and Growth Rate (2014-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Type (2014-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Comparison by Type in 2014 and 2020
Table Revenue (M USD) and Growth Rate (2014-2020)
Figure Revenue (M USD) and Growth Rate (2014-2020)
Table Revenue (M USD) and Growth Rate (2014-2020)
Figure Revenue (M USD) and Growth Rate (2014-2020)
Table Revenue (M USD) and Growth Rate (2014-2020)
Figure Revenue (M USD) and Growth Rate (2014-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Application (2014-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison by Application in 2014 and 2020
Table Sales (K Units) and Growth Rate (2014-2020)
Figure Sales (K Units) and Growth Rate (2014-2020)
Table Sales (K Units) and Growth Rate (2014-2020)
Figure Sales (K Units) and Growth Rate (2014-2020)
Table Sales (K Units) and Growth Rate (2014-2020)
Figure Sales (K Units) and Growth Rate (2014-2020)
Table Sales (K Units) and Growth Rate (2014-2020)
Figure Sales (K Units) and Growth Rate (2014-2020)
Table Sales (K Units) and Growth Rate (2014-2020)
Figure Sales (K Units) and Growth Rate (2014-2020)
Table Bracco Imaging S.P.A. Profiles
Table Bracco Imaging S.P.A. Product Information
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Cambridge Isotope Laboratories, Inc. Profiles
Table Cambridge Isotope Laboratories, Inc. Product Information
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Cardinal Health, Inc. Profiles
Table Cardinal Health, Inc. Product Information
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Covidien, Plc Profiles
Table Covidien, Plc Product Information
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Eczacibasi-Monrol Profiles
Table Eczacibasi-Monrol Product Information
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Fujifilm Holdings Corporation Profiles
Table Fujifilm Holdings Corporation Product Information
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table GE Healthcare (Subsidiary Of General Electric Company) Profiles
Table GE Healthcare (Subsidiary Of General Electric Company) Product Information
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table IBA Group Profiles
Table IBA Group Product Information
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Isotec, Inc. (Sigma-Aldrich) Profiles
Table Isotec, Inc. (Sigma-Aldrich) Product Information
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Lantheus Medical Imaging, Inc. Profiles
Table Lantheus Medical Imaging, Inc. Product Information
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Nordion, Inc. Profiles
Table Nordion, Inc. Product Information
Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Ntp Radioisotopes (Pty), Ltd. Profiles
Table Ntp Radioisotopes (Pty), Ltd. Product Information
Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Siemens Healthcare (Subsidiary Of Siemens AG) Profiles
Table Siemens Healthcare (Subsidiary Of Siemens AG) Product Information
Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Taiyo Nippon Sanso Corporation Profiles
Table Taiyo Nippon Sanso Corporation Product Information
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Urenco Limited Profiles
Table Urenco Limited Product Information
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Rotem Industries, Ltd., Inc. Profiles
Table Rotem Industries, Ltd., Inc. Product Information
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Australian Nuclear Association And Technology Organization (ANSTO) Profiles
Table Australian Nuclear Association And Technology Organization (ANSTO) Product Information
Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Board of Radiation And Isotope Technology (BRIT) Profiles
Table Board of Radiation And Isotope Technology (BRIT) Product Information
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Institute of Atomic Energy Polatom Radioisotope Centre Profiles
Table Institute of Atomic Energy Polatom Radioisotope Centre Product Information
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Institute of Isotopes Co., Ltd. Profiles
Table Institute of Isotopes Co., Ltd. Product Information
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Institute Of Radioelement (IRE) Profiles
Table Institute Of Radioelement (IRE) Product Information
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit (2014-2020)
Table SWOT Analysis
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity (K Units) of Manufacturers (2014-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share (%) of Manufacturers (2014-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Capacity Market Share (%) Comparison of Manufacturers (2014-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Comparison of Manufacturers in 2014 and 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
Figure Global Radiopharmaceuticals in Nuclear Medicine Gross Margin Comparison of Manufacturers in 2014 and 2020
Table Top 5 Manufacturers Sales Market Share (%) (2014-2020)
Table China Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2014-2020)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure China Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table China Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table China Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure China Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Comparison in 2014 and 2020
Table China Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
Figure China Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Comparison of Manufacturers in 2014 and 2020
Table China Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
Figure China Radiopharmaceuticals in Nuclear Medicine Gross Margin Comparison of Manufacturers in 2014 and 2020
Table Top 5 Manufacturers Sales Market Share (%) (2017-2019)
Table USA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Figure USA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2014-2020)
Figure USA Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure USA Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table USA Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table USA Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure USA Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Comparison in 2014 and 2020
Table USA Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
Figure USA Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Comparison of Manufacturers in 2014 and 2020
Table USA Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
Figure USA Radiopharmaceuticals in Nuclear Medicine Gross Margin Comparison of Manufacturers in 2014 and 2020
Table Top 5 Manufacturers Sales Market Share (%) (2017-2019)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2014-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Comparison in 2014 and 2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Comparison of Manufacturers in 2014 and 2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin Comparison of Manufacturers in 2014 and 2020
Table Top 5 Manufacturers Sales Market Share (%) (2017-2019)
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2014-2020)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table Japan Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Comparison in 2014 and 2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Comparison of Manufacturers in 2014 and 2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Gross Margin Comparison of Manufacturers in 2014 and 2020
Table Top 5 Manufacturers Sales Market Share (%) (2017-2019)
Table Korea Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2014-2020)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table Korea Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Comparison in 2014 and 2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Comparison of Manufacturers in 2014 and 2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Gross Margin Comparison of Manufacturers in 2014 and 2020
Table Top 5 Manufacturers Sales Market Share (%) (2017-2019)
Table India Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2014-2020)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table India Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table India Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Comparison in 2014 and 2020
Table India Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
Figure India Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Comparison of Manufacturers in 2014 and 2020
Table India Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
Figure India Radiopharmaceuticals in Nuclear Medicine Gross Margin Comparison of Manufacturers in 2014 and 2020
Table Top 5 Manufacturers Sales Market Share (%) (2017-2019)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2014-2020)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) Comparison in 2014 and 2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers (2014-2020)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Comparison of Manufacturers in 2014 and 2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers (2014-2020)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Gross Margin Comparison of Manufacturers in 2014 and 2020
Table Top 5 Manufacturers Sales Market Share (%) (2017-2019)
Table South America Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers (2014-2020)
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2014-2020)
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers (2014-2020)
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) Comparison of Manufacturers in 2014 and 2020
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers (2014-2020)
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers (2014-2020)
Figure South

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs